Get started
Author

Mauro Turrini

Observed names: M Turrini, M. Turrini, TURRINI, MAURO, Turrini, Mauro
Institution: Ospedale Valduce
ORCID: 0000-0001-5299-8456
Observed ORCID: 0000-0001-5299-8456
OpenAlex ID: A5001969333
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
2020 · Francesco Passamonti, Chiara Cattaneo, et al. · The Lancet Haematology · 558
PDF
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020 · Francesco Perrone, Maria Carmela Piccirillo, et al. · Journal of Translational Medicine · 144
PDF
Outcome of hyperleukocytic adult acute myeloid leukaemia: A single-center retrospective study and review of literature
2008 · Laura Marbello, Francesca Ricci, et al. · Leukemia Research · 92
Assessing Energy Expenditure in Cancer Patients: A Pilot Validation of a New Wearable Device
2007 · Emanuele Cereda, Mauro Turrini, et al. · Journal of Parenteral and Enteral Nutrition · 88
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way
2022 · Domenica Giannandrea, Natalia Platonova, et al. · Haematologica · 40
PDF
Old and new prognostic factors in acute myeloid leukemia with deranged core‐binding factor beta
2013 · Roberto Cairoli, Alessandro Beghini, et al. · American Journal of Hematology · 38
PDF
Down-regulation of MicroRNAs 222/221 in Acute Myelogenous Leukemia with Deranged Core-Binding Factor Subunits
2010 · Matteo Brioschi, John Fischer, et al. · Neoplasia · 38
PDF
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance
2019 · Michela Colombo, Silvia Garavelli, et al. · Haematologica · 33
PDF
Regeneration-associated WNT Signaling Is Activated in Long-term Reconstituting AC133bright Acute Myeloid Leukemia Cells
2012 · Alessandro Beghini, Francesca Corlazzoli, et al. · Neoplasia · 29
PDF
Phase II Trial of Weekly Intravenous Gemcitabine Administration With Interferon and Interleukin-2 Immunotherapy for Metastatic Renal Cell Cancer
2002 · B. Neri, L. Doni, et al. · The Journal of Urology · 26
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study
2002 · B Neri, G Cini, et al. · British Journal of Cancer · 25
PDF
Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)
2020 · Erika Borlenghi, Chiara Pagani, et al. · Journal of Geriatric Oncology · 22
Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial
2002 · B Neri, L Doni, et al. · Anti-Cancer Drugs · 21
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts
2023 · Luca Lanino, Francesco Restuccia, et al. · American Journal of Hematology · 19
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment
2019 · Alessandra Trojani, Ester Pungolino, et al. · PLoS ONE · 17
PDF
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature
2021 · Angelo Gardellini, Francesca Guidotti, et al. · Blood Cells Molecules and Diseases · 16
PDF
Microarray Demonstrates Different Gene Expression Profiling Signatures Between Waldenström Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance
2013 · Alessandra Trojani, Antonino Greco, et al. · Clinical Lymphoma Myeloma & Leukemia · 15
Gemcitabine plus Epi-doxorubicin as first-line chemotherapy for bladder cancer in advanced or metastatic stage: a phase II.
2002 · B Neri, L Doni, et al. · PubMed · 15
Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia
2016 · Francesca Lazzaroni, Luca Del Giacco, et al. · Scientific Reports · 13
PDF
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID ‐19: The GIMEMA EMATO ‐0321 study
2022 · Vincenzo Marasco, Alfonso Piciocchi, et al. · British Journal of Haematology · 12
PDF
Long-Term Survival in Metastatic Melanoma Patients Treated with Sequential Biochemotherapy: Report of a Phase II Study
2006 · B. Neri, L. Vannozzi, et al. · Cancer Investigation · 10
PDF
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial
2004 · B. Neri, G. Cipriani, et al. · Anti-Cancer Drugs · 10
Gilteritinib in FLT3‐mutated acute myeloid leukemia: A real‐world Italian experience
2025 · Roberto Cairoli, Lorenzo Del Castello, et al. · Cancer · 9
PDF
Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV
2022 · Patrizia Zappasodi, Chiara Cattaneo, et al. · Hematological Oncology · 9
PDF
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers
2025 · Elena Crisà, Daniela Cilloni, et al. · Cancers · 8
PDF
Works count: 80
Citation count: 1,388
H-index: 16
I10-index: 22
Year
Topic
Type